相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeting G542X CFTR nonsense alleles with ELX-02 restores CFTR function in human-derived intestinal organoids
Daniel K. Crawford et al.
JOURNAL OF CYSTIC FIBROSIS (2021)
A multicenter, randomized, placebo -controlled, double-blind phase 3 trial with open -arm comparison indicates safety and ef fi cacy of nephroprotective therapy with ramipril in children with Alport ? s syndrome see commentary
Oliver Gross et al.
KIDNEY INTERNATIONAL (2020)
Stop codon context influences genome-wide stimulation of termination codon readthrough by aminoglycosides
Jamie R. Wangen et al.
ELIFE (2020)
ELX-02 Generates Protein via Premature Stop Codon Read-Through without Inducing Native Stop Codon Read-Through Proteins
Daniel K. Crawford et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2020)
2,6-Diaminopurine as a highly potent corrector of UGA nonsense mutations
Carole Trzaska et al.
NATURE COMMUNICATIONS (2020)
Development of an exon skipping therapy for X-linked Alport syndrome with truncating variants in COL4A5
Tomohiko Yamamura et al.
NATURE COMMUNICATIONS (2020)
Isotopic Nitrogen-15 Labeling of Mice Identified Long-lived Proteins of the Renal Basement Membranes
Pan Liu et al.
SCIENTIFIC REPORTS (2020)
Genotype-phenotype correlations in fl uence the response to angiotensin-targeting drugs in Japanese patients with male X-linked Alport syndrome
Tomohiko Yamamura et al.
KIDNEY INTERNATIONAL (2020)
Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors
Andrew V. Anzalone et al.
NATURE BIOTECHNOLOGY (2020)
The antimalarial drug mefloquine enhances TP53 premature termination codon readthrough by aminoglycoside G418
Michael W. Ferguson et al.
PLOS ONE (2019)
New Negamycin-Based Potent Readthrough Derivative Effective against TGA-Type Nonsense Mutations
Keisuke Hamada et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
Advances in therapeutic use of a drug-stimulated translational readthrough of premature termination codons
Maciej Dabrowski et al.
MOLECULAR MEDICINE (2018)
Gentamicin induces LAMB3 nonsense mutation readthrough and restores functional laminin 332 in junctional epidermolysis bullosa
Vadim Lincoln et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
The minor gentamicin complex component, X2, is a potent premature stop codon readthrough molecule with therapeutic potential
Westley J. Friesen et al.
PLOS ONE (2018)
A Split-Luciferase-Based Trimer Formation Assay as a High-throughput Screening Platform for Therapeutics in Alport Syndrome
Kohei Omachi et al.
CELL CHEMICAL BIOLOGY (2018)
Factors influencing readthrough therapy for frequent cystic fibrosis premature termination codons
Iwona Pranke et al.
ERJ OPEN RESEARCH (2018)
Gentamicin induces functional type VII collagen in recessive dystrophic epidermolysis bullosa patients
David T. Woodley et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Characterization of new-generation aminoglycoside promoting premature termination codon readthrough in cancer cells
Laure Bidou et al.
RNA BIOLOGY (2017)
Structure-Activity Relationship Study of Leucyl-3-epideoxynegamycin for Potent Premature Termination Codon Readthrough
Akihiro Taguchi et al.
ACS MEDICINAL CHEMISTRY LETTERS (2017)
NanoLuc: A Small Luciferase Is Brightening Up the Field of Bioluminescence
Christopher G. England et al.
BIOCONJUGATE CHEMISTRY (2016)
Leveraging Rules of Nonsense-Mediated mRNA Decay for Genome Engineering and Personalized Medicine
Maximilian W. Popp et al.
CELL (2016)
Novel small molecules potentiate premature termination codon readthrough by aminoglycosides
Alireza Baradaran-Heravi et al.
NUCLEIC ACIDS RESEARCH (2016)
Ataluren stimulates ribosomal selection of near-cognate tRNAs to promote nonsense suppression
Bijoyita Roy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
X-Linked and Autosomal Recessive Alport Syndrome: Pathogenic Variant Features and Further Genotype-Phenotype Correlations
Judith Savige et al.
PLOS ONE (2016)
Nonsense suppression by near-cognate tRNAs employs alternative base pairing at codon positions 1 and 3
Bijoyita Roy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Synthetic Aminoglycosides Efficiently Suppress Cystic Fibrosis Transmembrane Conductance Regulator Nonsense Mutations and Are Enhanced by Ivacaftor
Xiaojiao Xue et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2014)
5-azacytidine inhibits nonsense-mediated decay in a MYC-dependent fashion
Madhuri Bhuvanagiri et al.
EMBO MOLECULAR MEDICINE (2014)
Designer Aminoglycosides That Selectively Inhibit Cytoplasmic Rather than Mitochondrial Ribosomes Show Decreased Ototoxicity A STRATEGY FOR THE TREATMENT OF GENETIC DISEASES
Eli Shulman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Feasibility of Repairing Glomerular Basement Membrane Defects in Alport Syndrome
Xiaobo Lin et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Ribosomal Readthrough at a Short UGA Stop Codon Context Triggers Dual Localization of Metabolic Enzymes in Fungi and Animals
Alina C. Stiebler et al.
PLOS GENETICS (2014)
Temporal and spatial characterization of nonsense-mediated mRNA decay
Tatjana Trcek et al.
GENES & DEVELOPMENT (2013)
Engineered Luciferase Reporter from a Deep Sea Shrimp Utilizing a Novel Imidazopyrazinone Substrate
Mary P. Hall et al.
ACS CHEMICAL BIOLOGY (2012)
Read-through compound 13 restores dystrophin expression and improves muscle function in the mdx mouse model for Duchenne muscular dystrophy
Refik Kayali et al.
HUMAN MOLECULAR GENETICS (2012)
Rescue of Melanocortin 4 Receptor (MC4R) Nonsense Mutations by Aminoglycoside-Mediated Read-Through
Harald Brumm et al.
OBESITY (2012)
Dissociation of antibacterial activity and aminoglycoside ototoxicity in the 4-monosubstituted 2-deoxystreptamine apramycin
Tanja Matt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Negamycin Analogue with Readthrough-Promoting Activity as a Potential Drug Candidate for Duchenne Muscular Dystrophy
Akihiro Taguchi et al.
ACS MEDICINAL CHEMISTRY LETTERS (2012)
Organogenesis of the kidney glomerulus Focus on the glomerular basement membrane
Jeffrey H. Miner et al.
ORGANOGENESIS (2011)
Repairing faulty genes by aminoglycosides: Development of new derivatives of geneticin (G418) with enhanced suppression of diseases-causing nonsense mutations
Igor Nudelman et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
The Alport Syndrome COL4A5 Variant Database
David K. Crockett et al.
HUMAN MUTATION (2010)
Nonaminoglycoside compounds induce readthrough of nonsense mutations
Liutao Du et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Clinical doses of amikacin provide more effective suppression of the human CFTR-G542X stop mutation than gentamicin in a transgenic CF mouse model
Ming Du et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2006)
Premature stop codons involved in muscular dystrophies show a broad spectrum of readthrough efficiencies in response to gentamicin treatment
L Bidou et al.
GENE THERAPY (2004)
Stable expression of nephrin and localization to cell-cell contacts in novel murine podocyte cell lines
D Schiwek et al.
KIDNEY INTERNATIONAL (2004)
Alport's syndrome, Goodpasture's syndrome, and type IV collagen
BG Hudson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome
O Gross et al.
KIDNEY INTERNATIONAL (2003)
Crystal structure of NC1 domains - Structural basis for type IV collagen assembly in basement membranes
M Sundaramoorthy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
分享论文
